Photodynamic Therapy vs Limited Macular Translocation in the Management of Subfoveal Choroidal Neovascularization in Pathologic Myopia: A Two-year Study

American Journal of Ophthalmology

Volumn 143, Issue 1, 2007, Pages

  Glacet Bernard, Agnès ^a   Benyelles, Nabil ^a   Dumas, Stéphane ^a   Haddad, Walid Michel ^a   Voigt, Monika ^a   Razavi, Sam ^a   Roquet, Wilfrid ^a   Coscas, Gabriel ^a   Soubrane, Gisèle ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; DIPLOPIA; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MYOPIA; PHOTODYNAMIC THERAPY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENT DISEASE; RETINA DETACHMENT; RETINA MACULA TRANSLOCATION; RETINA MACULOPATHY; RETROSPECTIVE STUDY; SUBRETINAL NEOVASCULARIZATION; TREATMENT INDICATION; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 33845510705     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2006.09.041     Document Type: Article

References (27)

1. Avila M.P., Weiter J.J., Jalkh A.E., Trempe C.L., Pruett R.C., and Schepens C.L. Natural history of choroidal neovascularization in degenerative myopia. Ophthalmology 91 (1984) 1573-1581
2. Hotchkiss M.L., and Fine S.L. Pathologic myopia and choroidal neovascularization. Am J Ophthalmol 91 (1981) 177-183
3. Curtin B.J. The posterior staphyloma of pathologic myopia. Trans Am Ophthalmol Soc 75 (1977) 67-86
4. Secretan M., Kuhn D., Soubrane G., and Coscas G. Long-term visual outcome of choroidal neovascularization in pathologic myopia: natural history and laser treatment. Eur J Ophthalmol 7 (1997) 307-316
5. Bottoni F., Airaghi P., Perego E., Ortolina S., Carlevaro G., and De Molfetta V. Surgical removal of idiopathic, myopic and age-related subfoveal neovascularization. Graefes Arch Clin Exp Ophthalmol 234 suppl 1 (1996) S42-S50
6. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial-VIP report no. 1. Ophthalmology 108 (2001) 841-852
7. Blinder K.J., Blumenkranz M.S., Bressler N.M., et al. Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial-VIP report no. 3. Ophthalmology 110 (2003) 667-673
8. Fujikado T., Ohji M., Saito Y., Hayashi A., and Tano Y. Visual function after foveal translocation with scleral shortening in patients with myopic neovascular maculopathy. Am J Ophthalmol 125 (1998) 647-656
9. Mateo C., Moreno J., Rosales G., et al. Two-year results of macular translocation with scleral infolding in myopic choroidal neovascularisation. Semin Ophthalmol 19 (2004) 29-42
10. Fujii G.Y., Humayun M.S., Pieramici D.J., Schachat A.P., Au Eong K.G., and de Juan Jr. E. Initial experience of inferior limited macular translocation for subfoveal choroidal neovascularization resulting from causes other than age-related macular degeneration. Am J Ophthalmol 131 (2001) 90-100
11. Glacet-Bernard A., Simon P., Hamelin N., Coscas G., and Soubrane G. Translocation of the macula for management of subfoveal choroidal neovascularization: comparison of results in age-related macular degeneration and degenerative myopia. Am J Ophthalmol 131 (2001) 78-89
12. Ichibe M., Imai K., Ohta M., Hasebe H., Yoshizawa T., and Abe H. Foveal translocation with scleral imbrication in patients with myopic neovascular maculopathy. Am J Ophthalmol 132 (2001) 164-171
13. de Juan Jr. E., Loewenstein A., Bressler N.M., and Alexander J. Translocation of the retina for management of subfoveal choroidal neovascularization II: a preliminary report in humans. Am J Ophthalmol 125 (1998) 635-646
14. Fujii G.Y., de Juan Jr. E., Au Eong K.G., and Harlan Jr. J.B. Effective nasal limited macular translocation. Am J Ophthalmol 132 (2001) 124-126
15. Glacet-Bernard A., Coscas G., and Soubrane G. Pigment epithelial changes in young women treated with photodynamic therapy and limited macular translocation for classic choroidal neovascularisation. Graefes Arch Clin Exp Ophthalmol 244 (2006) 1373-1376
16. Postelmans L., Pasteels B., Coquelet P., El Ouardighi H., Verougstraete C., and Schmidt-Erfurth U. Severe pigment epithelial alterations in the treatment area following photodynamic therapy for classic choroidal neovascularization in young females. Am J Ophthalmol 138 (2004) 803-808
17. Spaide R.F., Sorenson J., and Maranan L. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization. Ophthalmology 112 (2005) 301-304
18. Ergun E., Maar N., Ansari-Shahrezaei S., et al. Photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide in the treatment of neovascular age-related macular degeneration. Am J Ophthalmol 142 (2006) 10-16
19. Hamelin N., Glacet-Bernard A., Brindeau C., Mimoun G., Coscas G., and Soubrane G. Surgical treatment of subfoveal neovascularization in myopia: macular translocation vs surgical removal. Am J Ophthalmol 133 (2002) 530-536
20. Denion E., Ordonez R., Klein J.C., Glacet-Bernard A., and Caputo G. Redistribution of the neurosensory retina in inferior limited macular translocation: an evaluation using image registration. Graefes Arch Clin Exp Ophthalmol (2006) August 31 [Epub ahead of print]
21. Kamei M., Tano Y., Yasuhara T., Ohji M., and Lewis H. Macular translocation with chorioscleral outfolding: 2-year results. Am J Ophthalmol 138 (2004) 574-581
22. Fujii G.Y., Pieramici D.J., Humayun M.S., et al. Complications associated with limited macular translocation. Am J Ophthalmol 130 (2000) 751-762
23. Pawlak D., Glacet-Bernard A., Papp M., Roquet W., Coscas G., and Soubrane G. Limited macular translocation compared with photodynamic therapy in the management of subfoveal choroidal neovascularization in age-related macular degeneration. Am J Ophthalmol 137 (2004) 880-887
24. Simon P., Glacet-Bernard A., Coscas G., and Soubrane G. Progression of choroidal neovascularization after macular translocation in age-related macular degeneration and degenerative myopia. J Fr Ophtalmol 25 (2002) 694-700
25. D'Amico D.J., Patel M., Adamis A.P., Cunningham Jr. E.T., Guyer D.R., and Katz B. Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials. Ophthalmology 113 (2006) e1001-e1006
26. Yoshida T., Ohno-Matsui K., Ohtake Y., et al. Long-term visual prognosis of choroidal neovascularization in high myopia: a comparison between age groups. Ophthalmology 109 (2002) 712-719
27. Ergun E., Heinzl H., and Stur M. Prognostic factors influencing visual outcome of photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia. Am J Ophthalmol 138 (2004) 434-438